Affordable Access

deepdyve-link
Publisher Website

Systematic reviews reveal unrepresentative evidence for the development of drug formularies for poor and nonwhite populations.

Authors
  • Odierna, Donna H1
  • Bero, Lisa A
  • 1 Department of Clinical Pharmacy, University of California, San Francisco, 94118, USA. [email protected]
Type
Published Article
Journal
Journal of clinical epidemiology
Publication Date
December 2009
Volume
62
Issue
12
Pages
1268–1278
Identifiers
DOI: 10.1016/j.jclinepi.2009.01.009
PMID: 19375890
Source
Medline
License
Unknown

Abstract

DERP reviews reveal deficiencies of the evidence when applied to Medicaid populations. To increase health equity and provide evidence for policies that serve socially disadvantaged populations, drug trials, and other studies should include more members of these populations. Systematic reviews should include low-SES as a prespecified subgroup.

Report this publication

Statistics

Seen <100 times